Immunology Devices Panel Nov. 13, 2019 Transcript
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
APPROPRIATE HEALTH TECHNOLOGY Emlrc44itech.Disc./1
WORLD HEALTH ORGANIZATION ~egional Office for the Eastern Mediterranean ORGANISATION MONDIALE DE LA SANTE Bureau regional de la Mediterranee orientale REGIONAL COMMITTEE FOR THE EMlRC44/Tech.Disc'/l EASTERN MEDITERRANEAN August 1997 Forty-fourth Session Original: Arabic Agenda item 7 TECHNICAL DISCUSSIONS APPROPRIATE HEALTH TECHNOLOGY EMlRC44ITech.Disc./1 CONTENTS page Executive Summary 1. Introduction....................................................................................................... 1 2. Definitions......................................................................................................... 1 2.1 Health technology..................................................................................... I 2.2 Appropriate technology............................................................................. I 3. Appropriate technology and future trends........................................................... 3 3. I General..................................................................................................... 3 3.2 Health care.................................................................... ............................ 3 3.3 Gene technology..... ....... ....... ............ ........................................................ 4 3.4 Laboratory medicine technologies............................................................. 4 3.5 Transfusion medicine................................................................................. 5 3.6 Diagnostic imaging................................................................................... -
The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine in This Issue
June 2021 ISSN 1650-3414 Volume 32 Number 2 Communications and Publications Division (CPD) of the IFCC Editor-in-chief: Prof. János Kappelmayer, MD, PhD Faculty of Medicine, University of Debrecen, Hungary e-mail: [email protected] The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine In this issue Introducing the eJIFCC special issue on “POCT – making the point” Guest editor: Sergio Bernardini 116 Controlling reliability, interoperability and security of mobile health solutions Damien Gruson 118 Best laboratory practices regarding POCT in different settings (hospital and outside the hospital) Adil I. Khan 124 POCT accreditation ISO 15189 and ISO 22870: making the point Paloma Oliver, Pilar Fernandez-Calle, Antonio Buno 131 Utilizing point-of-care testing to optimize patient care James H. Nichols 140 POCT: an inherently ideal tool in pediatric laboratory medicine Siobhan Wilson, Mary Kathryn Bohn, Khosrow Adeli 145 Point of care testing of serum electrolytes and lactate in sick children Aashima Dabas, Shipra Agrawal, Vernika Tyagi, Shikha Sharma, Vandana Rastogi, Urmila Jhamb, Pradeep Kumar Dabla 158 Training and competency strategies for point-of-care testing Sedef Yenice 167 Leading POCT networks: operating POCT programs across multiple sites involving vast geographical areas and rural communities Edward W. Randell, Vinita Thakur 179 Connectivity strategies in managing a POCT service Rajiv Erasmus, Sumedha Sahni, Rania El-Sharkawy 190 POCT in developing countries Prasenjit Mitra, Praveen Sharma 195 In this issue How could POCT be a useful tool for migrant and refugee health? Sergio Bernardini, Massimo Pieri, Marco Ciotti 200 Direct to consumer laboratory testing (DTCT) – opportunities and concerns Matthias Orth 209 Clinical assessment of the DiaSorin LIAISON SARS-CoV-2 Ag chemiluminescence immunoassay Gian Luca Salvagno, Gianluca Gianfilippi, Giacomo Fiorio, Laura Pighi, Simone De Nitto, Brandon M. -
Metallosis and Pseudotumor Around Ceramic-On-Polyethylene Total Hip Arthroplasty; Case Report and Literature Review
Available online at www.ijmrhs.com Special Issue 9S: Medical Science and Healthcare: Current Scenario and Future Development International Journal of Medical Research & ISSN No: 2319-5886 Health Sciences, 2016, 5, 9S:518-524 Metallosis and Pseudotumor around Ceramic-On-Polyethylene Total Hip Arthroplasty; Case Report and Literature Review Afshin Taheriazam 1* and Amin Saeidinia 2,3 1Hip Surgeon, Assistant Professor, Department of Orthopedics Surgery, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran 2General Practitioner, Assistant Researcher, Mashhad University of Medical Sciences, Mashhad, Iran 3Member of Young Researchers Club, Rasht Branch, Islamic Azad University, Rasht, Iran *Corresponding Email: [email protected] _____________________________________________________________________________________________ ABSTRACT Polyethylene failure is a rare complication of ceramic-on-polyethylene total hip arthroplasty due to characteristics of ceramic. Complications associated with ceramic-on-polyethylene articulations have been studied extensively, however, only few reports have described its catastrophic wear and concurrent pseudotumor formation. The etiology of this biological reaction and concurrency of pseudotumor formation with metallosis remain unclear. We report two cases of wear of the acetabular liner in a ceramic-on-polyethylene prosthesis due to total hip arthroplasty (THA) long time ago. They came back to the clinic with the history of worsening hip pain and abnormal radiological and clinical findings. Then they underwent surgery and metallosis and pseudotumors were detected and revisions were performed for them. It is necessary to evaluate patients underwent THA complaining of hip pain for component wear and be checked the cup appear well fixing and fairly oriented on follow-up radiographies. Close follow ups can prevent accelerated polyethylene wear in ceramic-on-polyethylene coupling THA. -
Strengthening Care Management with Health Information Technology a Learning Guide
Strengthening Care Management with Health Information Technology A Learning Guide Presenting lessons learned by the 17 Beacon Community Awardees of the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services July 2013 i The Beacon Community Cooperative Agreement Program demonstrates how health IT investments and Meaningful Use of electronic health records (EHR) advance the vision of patient-centered care, while achieving the three-part aim of better health, better care at lower cost. The Department of Health and Human Services, Office of the National Coordinator for Health IT (ONC) is providing $250 million over three years to 17 selected communities throughout the United States that have already made inroads in the development of secure, private, and accurate systems of EHR adoption and health information exchange. Each of the 17 communities—with its unique population and regional context—is actively pursuing the following areas of focus: • Building and strengthening the health IT infrastructure and exchange capabilities within communities, positioning each community to pursue a new level of sustainable health care quality and efficiency over the coming years; • Translating investments in health IT to measureable improvements in cost, quality and population health; and • Developing innovative approaches to performance measurement, technology and care delivery to accelerate evidence generation for new approaches. For more information about the Beacon Community Program visit www.healthit.gov. This Learning Guide is part of the Beacon Nation project and is funded by the Hawai’i Island Beacon Community, an awardee of ONC Beacon Community Program. The Learning Guide was produced by Booz Allen Hamilton, under a contract with the Hawai’i Island Beacon Community. -
How to Leverage Health Technology to Improve Patient Flow
How to Leverage Health Technology to Improve Patient Flow 3/31/2017 A growing population has led to an increased demand for healthcare services. Concurrently, healthcare reforms and reimbursement requirements necessitate improvements in quality care and patient satisfaction. Healthcare facilities have begun searching for ways in which to handle the influx of patients without sacrificing either quality or the patient experience. How can your facility achieve increased volume and profits while maintaining quality and improving patient satisfaction? This whitepaper addresses how RTLS (Real Time Locating System) technology can be implemented to solve critical issues such as: · Increased capacity · Decreased waiting times · Patient and staff satisfaction · Increased healthcare staff productivity Increased Capacity The aging population in the United States is requiring more healthcare services. As the Baby Boomer population ages, almost twenty percent of the current population living in the United States will reach age 65 or older. This increase in the aging population leads to a significant growth in the number of individuals with chronic conditions. According to the American Hospital Association, the number of Boomers with multiple chronic conditions is continuing to grow and will reach about 37 million adults by 2030.i The prevalence of chronic conditions is also increasing in the United States population as a whole and calls for increased medical services and innovative approaches on how to properly deliver care to this population. Many healthcare delivery systems are utilizing RTLS technology to meet the increased population challenge. The Nor-Lea Medical Clinic in Lovington, New Mexico implemented an RTLS system to handle their growing influx of patients. -
1995) Borrelia Burgdorferi-Specific T Lymphocytes Induce Severe Destructive Lyme Arthritis
LTT (Lymphozyten-Proliferationstest, „Lymphozyten-Transformationstest“) Interferon Gamma Test, ELISpot (T-Cell Spot), dem Lymphozytentransformationstest bei Borreliose und bei anderen Infektionskrankheiten Im Lymphozyten-Proliferationstest, auch Lymphozyten-Transformationstest genannt (LTT), wird die Proliferationskapazität von Lymphozyten dargestellt. Der Test dient der Bewertung des Immunstatus oder der Diagnose einer speziellen Sensibilisierung. In the Lymphocyte proliferation assay, also known as lymphocyte transformation test (LTT), the proliferation capacity of lymphocytes is shown. The test is used to evaluate the immune status or the diagnosis of specific sensitization of an object. Im Interferon Gamma Test, dem ELISPOT (Enzyme-Linked ImmunoSpot), auch T- Cellspot genannt, wird durch die Bestimmung der Zytokin – Produktion die Quantität und die Qualität einer T – Zell - Immunantwort zeitnah dokumentiert. In the Interferone Gamma Test, ELISPOT (Enzyme-Linked ImmunoSpot), also called T-Cell spot, represented by the determination of cytokine – Production, the quantity and quality of T - cell - immune response in a timely manner is documented. Lim LC, England DM, DuChateau BK, Glowacki NJ, Schell RF (1995) Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63, 1400-1408. Dwyer JM et al. (1979) Behavior of human immunoregulatory cells in culture. L Variables requiring consideration for clinical studies. Clin Exp Immunol 38, 499-513 Johnson C, Dwyer JM (1981) Quantitation of spontaneous suppressor cell activity in human cord blood lymphocytes and their behavior in culture (abstract). Fed Proc 40, 1075 Czerkinsky C, Nilsson L, Nygren H, Ouchterlony O, Tarkowski A (1983) A solid-phase enzyme- linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.J Immunol Methods 65 (1–2), 109–121. -
Biomedical Engineering (BMD ENG) 1
Biomedical Engineering (BMD_ENG) 1 Through the course, students will learn how to apply these experimental BIOMEDICAL ENGINEERING and computational genomics technologies to study gene expression regulation underlying various biological processes, such as oncogenesis. (BMD_ENG) Students will also apply computational and statistical skills, using linux and R/Matlab/Python. BMD_ENG 101-0 Introduction to Biomedical Engineering (0 Unit) BMD_ENG 317-0 Biochemical Sensors (1 Unit) Information to 1) help students determine if BME is the right major Theory, design, and applications of chemical sensors used in medical for them and 2) learn how to make the most of their undergraduate diagnosis and patient monitoring. Electrochemical and optical sensors. experience. The field of biomedical engineering, career and research Prerequisites: BIOL_SCI 215-0; BIOL_SCI 219-0; CHEM 210-1; opportunities, ethics. PHYSICS 135-2; PHYSICS 135-3. BMD_ENG 207-0 BME Lab: Experimental Design (0.5 Unit) A laboratory BMD_ENG 323-0 Visual Engineering Science (1 Unit) course focusing on quantitative physiological measurements Mammalian visual system. Physiological optics. Visual image and analyses, instrument characterization, statistical design of representation and interpretation. Visual adaptation. Motion. Color vision. experiments, and training in preparation and organization of laboratory Prerequisite: PHYSICS 135-2. notes and reports. Prerequisite: BMD_ENG 220-0 or IEMS 303-0 or MECH_ENG 359-0. BMD_ENG 325-0 Introduction to Medical Imaging (1 Unit) Diagnostic X-rays; X-ray film and radiographic image; computed BMD_ENG 220-0 Introduction to Biomedical Statistics (1 Unit) Basic tomography; ultrasound. statistical concepts presented with emphasis on their relevance to Prerequisite: PHYSICS 135-3 or equivalent. biological and medical investigations. -
Executive Brief: Top 10 Health Technology Hazards for 2017
EXECUTIVE BRIEF Top 10 Health Technology Hazards for 2017 A Report from Health Devices November 2016 EXECUTIVE BRIEF Top 10 Health Technology Hazards for 2017 A Report from Health Devices November 2016 Top 10 Health Technology Hazards for 2017 Executive Brief ECRI Institute is providing this abridged version of its 2017 Top 10 list of health technology hazards as a free public service to inform healthcare facilities about important safety issues involving the use of medical devices and systems. The full report— including detailed problem descriptions and ECRI Institute’s step-by-step recommendations for addressing the hazards—is available to members of certain ECRI Institute programs through their membership web pages. The List for 2017 1. Infusion Errors Can Be Deadly If Simple Safety Steps Are Overlooked 2. Inadequate Cleaning of Complex Reusable Instruments Can Lead to Infections 3. Missed Ventilator Alarms Can Lead to Patient Harm 4. Undetected Opioid-Induced Respiratory Depression 5. Infection Risks with Heater-Cooler Devices Used in Cardiothoracic Surgery 6. Software Management Gaps Put Patients, and Patient Data, at Risk 7. Occupational Radiation Hazards in Hybrid ORs 8. Automated Dispensing Cabinet Setup and Use Errors May Cause Medication Mishaps 9. Surgical Stapler Misuse and Malfunctions 10. Device Failures Caused by Cleaning Products and Practices The Purpose of the List The safe use of health technology—from basic infusion pumps to large, complex imaging systems—requires identifying possible sources of danger or difficulty with those technologies and taking steps to minimize the likelihood that adverse events will occur. This list will help healthcare facilities do that. -
Ampath Medical Surveillance Guidelines Metal Chemicals
AMPATH MEDICAL SURVEILLANCE GUIDELINES METAL CHEMICALS TABLE OF CONTENTS Introduction 3 Definitions 4 Biological monitoring 7 Biological effect monitoring 15 Health program 15 Food handler’s health program 16 Driver’s health program 16 Substance abuse in the workplace 17 Alcohol in the workplace 17 Target organs for alcohol abuse 21 Drugs in the workplace 22 Ampath drugs of abuse screening and confirmatory tests on urine 23 Conditions under which a pathologist will testify in court 23 Chain of custody 24 Hazardous chemical regulations 25 Designing and implementing a program of medical surveillance 25 Assessment of potential exposure 25 Table 3 substances 26 Available tests 27 Test interpretation 31 Ampath Quality Assurance 33 Designing exposure profiles 34 Work related hazardous chemical exposure 36 Chemical exposure: DNA adducts 37 Target organs for chemical exposure 39 Chemical exposure profiles 40 Aniline 40 Acetone 41 Benzene 42 Carbon disulphide 43 Carbon monoxide 44 Cyanide 45 Ethyl benzene 46 NN-dimethylformamide 47 Furfural 48 N-hexane 49 © Ampath Medical Surveillance Guideline 1 Isocyanate 50 Methanol 51 Methyl chloroform 52 Methyl ethyl ketone 53 Methyl isobutyl ketone 54 Nitrobenzene 55 Organophosphorous cholinesterase inhibitors 56 Paraquat 57 Parathion 58 Pentachlorophenol 59 Perchloroethylene 60 Phenol 61 Polycyclic aromatic hydrocarbon(PAH) 62 Styrene 64 Toluene 65 Trichloroethylene 67 Xylene 68 Metals 69 Diagnosis and investigation of occupational exposure to metals; a general review 69 Target organs for metal exposure -
Metallosis After Reverse Total Shoulder Arthroplasty
Edorium J Orthop 2017;3:17–23. Rondon et al. 17 www.edoriumjournaloforthopedics.com CASE REPORT PEER REVIEWED OPEN| OPEN ACCESS ACCESS Metallosis after reverse total shoulder arthroplasty Alexander J. Rondon, Tyler R. Clark, Felix H. Savoie ABSTRACT environment. Conclusion: Future consideration must be given to the size and angle of the Introduction: We present a case of metallosis humeral and glenoid components in reverse following a reverse total shoulder arthroplasty. total shoulder arthroplasties. It is our hope that We are not aware of any cases described in our case emphasizes the importance of proper literature of metallosis following reverse total prosthetic placement and establishes a higher shoulder arthroplasty with well-fixed implants. level of suspicion for metallosis as a complication To date, there have been four cases described in for reverse total shoulder arthroplasties. literature that have found metallosis following shoulder replacement surgery: three following Keywords: Arthroplasty, Metallosis, Reverse, hemiarthroplasty and one following total shoulder Shoulder arthroplasty. Case Report: Our patient dislocated seven months postoperatively, and with concern How to cite this article of further instability as noted on examination, the patient was taken to the operating room for Rondon AJ, Clark TR, Savoie FH. Metallosis after glenosphere and liner exchange. During surgery, reverse total shoulder arthroplasty. Edorium J severe metallic staining was discovered in the Orthop 2017;3:17–23. joint as well as significant inferomedial wear to the polyethylene insert. This was likely due to instability as a result of inadequate tension on Article ID: 100007O03AR2017 the deltoid muscle, inadequate liner size, early hypermobility, downward tilt of the glenoid, and failure to lateralize the component sufficiently. -
Curriculum & Syllabi
CURRICULUM & SYLLABI B.TECH DEGREE PROGRAMME BIOMEDICAL ENGINEERING DEPARTMENT OF ELECTRONICS AND INSTRUMENTATION ENGINEERING KARUNYA UNIVERSITY, COIMBATORE INDIA Table BM-1 B.Tech. (Biomedical Engineering)–2014 batch COURSE COMPONENTS Excluding PEP subjects(First Year) Table 1 General – 2 credits Credits Sl. No. Sub.Code Course 1 14VE2001 Value Education I / II 2:0:0 /14VE2002 Course Total 2 Table 2 Basic Sciences – 12 credits Credits Sl. No. Sub.Code Course 1 14MA2003 Mathematical Transforms 3:1:0 2 14MA2015 Probability, Random Process and Numerical Methods 3:1:0 3 15BT2001 Medical Biochemistry 3:0:0 4 15BT2002 Medical Biochemistry Laboratory 0:0:1 Course Total 12 Table 3 Engineering Sciences & Technical Credits Sl. No. Sub.Code Arts – 6 credits Course 1 14MS2002 Managerial Skills 3:0:0 2 15EI2001 Health and Hospital Management 3:0:0 Course Total 6 Table 4 Program Core – 75 credits & a full / part semester Sl.No Sub.Code project NameoftheCourse Credits 1 14EE2001 Electric Circuits and Networks 3:1:0 2 14EC2001 Digital Electronics 3:1:0 3 15EI2002 Medical Electronics 3:0:0 4 15EI2003 Biomedical Sensors and Transducers 3:0:0 5 14EC2005 Electron Devices and Circuits Lab 0:0:2 6 15EI2004 Biomedical Sensors and Transducers Laboratory 0:0:2 7 15BT2003 Human Anatomy and Physiology 3:0:0 8 14EC2003 Signals and Systems 3:1:0 9 15EI2005 Biosignal Conditioning Circuits 3:0:0 10 15EI2006 Biocontrol systems 3:1:0 11 15EI2007 Medical Diagnostic Equipment 3:0:0 12 14EC2014 Digital Signal Processing 3:1:0 13 15EI2008 Biosignal Processing Laboratory -
Medical Laboratory Technology Program at Florida State College at Jacksonville
Revised 4/23/19 School of Health, Education and Human Services Health Program Application Florida State College at Jacksonville 4501 Capper Road, Jacksonville, Florida 32218 Personal Information: Please Print Student Name: EMPL # (number on back of student ID) _______________ Last Four of Social Security #: __________ In compliance with Florida State Statute 119.071(5), students should be aware that Florida State College at Jacksonville collects and uses social security numbers (SSNs) if specifically required by law to do so or if necessary for the performance of the College's duties and responsibilities. The College takes appropriate measures to secure SSNs from unauthorized access and does not release SSNs to other parties except as required to fulfill the College's duties and responsibilities. View full list of SSN collection purposes. Street Address: City, State, Zip Personal Email _________________________FSCJ Email _________________________ Home Phone: ______________________ Cell Phone: __________________________ Birthdate: ____________________ Sex: Male ☐ Female ☐ Race: Black ☐ American Indian ☐ Alaskan Native ☐ White (Not Hispanic Origin) ☐ Asian Or Pacific Islander ☐ Hispanic ☐ Certification: I, certify that all information given in this application is true and accurate to the best of my knowledge. I understand that if I have falsified any information, I am subject to immediate dismissal from the School of Health and Human Services program for which I am selected. I understand that all correspondence regarding the program will be sent to my Florida State College at Jacksonville email account. All applicants will be notified of their status 2 to 3 weeks after deadline date. Signature: Date ______________ Participation in any health science program requires a medical history and physical examination, including a record of immunizations.